PE medications are usually considered before medical procedures. Learn more about medications for PE, including the types, goals, and risk factors. Medications for PE fall into two categories ...

The trial adds much-needed randomized data to an area where it’s been lacking. Questions about methods muddy interpretation.

(Nasdaq:NARI) today announced positive results from its prospective PEERLESS trial for the FlowTriever system.

Baron Discovery Fund highlighted stocks like Inari Medical, Inc. (NASDAQ:NARI) in the third quarter 2024 investor letter.

The Massachusetts Health Policy Commission does not expect the Stewardship sale to increase spending or decrease care quality ...

In October, Archimed bought FIM Medical, in its latest acquisition. The company provides vision, hearing and respiratory care ...

We added to our position in Inari Medical this quarter at what, we believe, are attractive valuations. Click here for our ...

WellSky, which is backed by Leonard Green & Partners and TPG, has acquired Bonafide, an Thousand Oaks, California-based enterprise software solution for durable medical equipment and home medical ...

Inquis Medical has raised $40 million in funding to support the development of its mechanical blood clot removal system. | ...

Akura Medical, a Shifamed portfolio company, announced today that the FDA granted its Katana system investigational device exemption (IDE).

The FlowTriever system is 510(k)-Cleared by FDA and CE Mark approved for the treatment of pulmonary embolism and clot in transit in the right atrium. Inari Medical NewsMORE Related Stocks ...